Literature DB >> 24202191

Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.

Marie Fabritius1, Haithem Chtioui, Giovanni Battistella, Jean-Marie Annoni, Kim Dao, Bernard Favrat, Eleonora Fornari, Estelle Lauer, Philippe Maeder, Christian Giroud.   

Abstract

A cross-over controlled administration study of smoked cannabis was carried out on occasional and heavy smokers. The participants smoked a joint (11% Δ9-tetrahydrocannabinol (THC)) or a matching placebo on two different occasions. Whole blood (WB) and oral fluid (OF) samples were collected before and up to 3.5 h after smoking the joints. Pharmacokinetic analyses were obtained from these data. Questionnaires assessing the subjective effects were administered to the subjects during each session before and after the smoking time period. THC, 11-hydroxy-THC (11-OH-THC) and 11-nor-9-carboxy-THC (THCCOOH) were analyzed in the blood by gas chromatography or liquid chromatography (LC)-tandem mass spectrometry (MS/MS). The determination of THC, THCCOOH, cannabinol (CBN), and Δ9-tetrahydrocannabinolic acid A (THC-A) was carried out on OF only using LC-MS/MS. In line with the widely accepted assumption that cannabis smoking results in a strong contamination of the oral cavity, we found that THC, and also THC-A, shows a sharp, high concentration peak just after smoking, with a rapid decrease in these levels within 3 h. No obvious differences were found between both groups concerning THC median maximum concentrations measured either in blood or in OF; these levels were equal to 1,338 and 1,041 μg/L in OF and to 82 and 94 μg/L in WB for occasional and heavy smokers, respectively. The initial WB THCCOOH concentration was much higher in regular smokers than in occasional users. Compared with the occasional smokers, the sensation of confusion felt by the regular smokers was much less while the feeling of intoxication remained almost unchanged.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24202191     DOI: 10.1007/s00216-013-7412-1

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  15 in total

1.  THC and CBD blood and brain concentrations following daily administration to adolescent primates.

Authors:  S L Withey; J Bergman; M A Huestis; S R George; B K Madras
Journal:  Drug Alcohol Depend       Date:  2020-06-18       Impact factor: 4.492

2.  Pharmacokinetics of Cannabis Brownies: A Controlled Examination of Δ9-Tetrahydrocannabinol and Metabolites in Blood and Oral Fluid of Healthy Adult Males and Females.

Authors:  Tory R Spindle; Edward J Cone; Evan S Herrmann; John M Mitchell; Ronald Flegel; Charles LoDico; George E Bigelow; Ryan Vandrey
Journal:  J Anal Toxicol       Date:  2020-10-12       Impact factor: 3.367

3.  Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes.

Authors:  Ryan Vandrey; Evan S Herrmann; John M Mitchell; George E Bigelow; Ronald Flegel; Charles LoDico; Edward J Cone
Journal:  J Anal Toxicol       Date:  2017-03-01       Impact factor: 3.367

4.  Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.

Authors:  Tory R Spindle; Edward J Cone; Nicolas J Schlienz; John M Mitchell; George E Bigelow; Ronald Flegel; Eugene Hayes; Ryan Vandrey
Journal:  J Anal Toxicol       Date:  2019-05-01       Impact factor: 3.367

5.  Cannabinoid concentrations in confiscated cannabis samples and in whole blood and urine after smoking CBD-rich cannabis as a "tobacco substitute".

Authors:  Marianne Hädener; Tim J Gelmi; Marie Martin-Fabritius; Wolfgang Weinmann; Matthias Pfäffli
Journal:  Int J Legal Med       Date:  2019-01-05       Impact factor: 2.686

6.  Medicinal Cannabis for the Treatment of Chronic Refractory Pain: An Investigation of the Adverse Event Profile and Health-Related Quality of Life Impact of an Oral Formulation.

Authors:  Sarah Abelev; Leon N Warne; Melissa Benson; Mark Hardy; Sunny Nayee; John Barlow
Journal:  Med Cannabis Cannabinoids       Date:  2022-02-09

7.  Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships.

Authors:  Rebecca L Hartman; Timothy L Brown; Gary Milavetz; Andrew Spurgin; David A Gorelick; Gary Gaffney; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2015-08-10       Impact factor: 3.345

8.  Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips.

Authors:  Maria Andersson; Karl B Scheidweiler; Cristina Sempio; Allan J Barnes; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2016-07-15       Impact factor: 4.142

Review 9.  Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?

Authors:  Mahmoud Abu-Amna; Talal Salti; Mona Khoury; Idan Cohen; Gil Bar-Sela
Journal:  Curr Treat Options Oncol       Date:  2021-01-13

10.  Preliminary Evidence for Cannabis and Nicotine Urinary Metabolites as Predictors of Verbal Memory Performance and Learning Among Young Adults.

Authors:  Natasha E Wade; Rachel Baca; Kelly E Courtney; Connor J McCabe; M Alejandra Infante; Marilyn A Huestis; Joanna Jacobus
Journal:  J Int Neuropsychol Soc       Date:  2021-07       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.